Rare diseases
Investigational molecules
Locations
345 conditions with trials, the busiest first
956 trials across Europe, recruiting first
A Study of Disitamab Vedotin for Adults with HER2 Expressing Advanced Breast Cancer
GermanyStudy to evaluate gadopiclenol-enhanced magnetic resonance imaging for diagnosis in patients with breast cancer
SpainLong-term safety study of ribociclib with letrozole, tamoxifen, or goserelin acetate in patients with HR-positive, HER2-negative advanced or metastatic breast cancer
GreeceStudy of Datopotamab Deruxtecan with or without Durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
BelgiumStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
AustriaStudy of luxdegalutamide and abiraterone combination in adult men with metastatic hormone-sensitive prostate cancer
CzechiaStudy of JSB462 and lutetium (177Lu) vipivotide tetraxetan combination for adult men with PSMA-positive metastatic castration resistant prostate cancer
AustriaStudy of Saruparib in Patients with Advanced or Recurrent Ovarian Cancer to Assess Safety and Effectiveness
ItalyStudy of ifinatamab deruxtecan alone or in combination with other treatments for patients with metastatic castration-resistant prostate cancer
FranceStudy of 89Zr-trastuzumab PET/CT imaging and trastuzumab emtansine treatment in patients with advanced HER2-positive breast cancer
BelgiumEvaluation of COM701 as Maintenance Therapy for Patients with Relapsed Platinum-Sensitive Ovarian Cancer
FranceStudy on Estriol Vaginal Ring for Treating Vaginal Atrophy in Postmenopausal Women
GermanyThe therapies tested most often in Reproductive system and breast disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
